on 26 Mar 2024
Last Applicant/ Owned by
10230 Jasper Avenue
Edmonton, Alberta
CA
T5J4P6
Serial Number
97977591 filed on 14th Sep 2022
Registration Number
N/A
Correspondent Address
Theodore R. Remaklus
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
Advisory services relating to gene therapy research; research in the field of gene therapy; research and development of vaccines and medicines; information on the subject of scientific research in the field of biotechnology; genetic testing for scientific research purposes; scientific research in the field of genetics and genetic engineering; research and development in the pharmaceutical and biotRead More
Medical therapy services, namely, gene therapy services; medical analysis services, namely, RNA or DNA analysis for virus diagnosis and prognosis; medical information services, namely, providing information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, recombinant proteins and antibodies, diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies; on-line information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, recombinant proteins and antibodies, diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies; genetic testing for medical purposes
31st Mar 2011
31st Mar 2011
Advisory services relating to gene therapy research; research in the field of gene therapy; research and development of vaccines and medicines; information on the subject of scientific research in the field of biotechnology; genetic testing for scientific research purposes; scientific research in the field of genetics and genetic engineering; research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development in the field of therapeutic and diagnostic products; scientific research, pharmaceutical research, medical research, technical consultation in the field of pharmaceutical studies and product development for others in the field of biotechnology and product development of pharmaceuticals, therapeutic agents and medical devices; research and product development in the field of human vaccines, recombinant proteins and antibodies for therapeutic use; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; medical and scientific research services relating to infectious diseases; development of new products for others in the field of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies; medical and scientific research regarding clinical trial studies on new vaccine candidates
31st Mar 2011
31st Mar 2011
Custom manufacture of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies for others; custom manufacturing of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies
31st Mar 2011
23rd Jan 2018
No 97977591
No Service Mark
No TORYS-96-122
Yes
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 10th Apr 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 22nd Mar 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 12th Mar 2024 | EXAMINER'S AMENDMENT ENTERED |
| 11th Mar 2024 | EXAMINERS AMENDMENT -WRITTEN |
| 11th Mar 2024 | EXAMINERS AMENDMENT E-MAILED |
| 11th Mar 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 11th Mar 2024 | ASSIGNED TO LIE |
| 08th Mar 2024 | DIVISIONAL PROCESSING COMPLETE |
| 06th Mar 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 16th Nov 2023 | TEAS REQUEST TO DIVIDE RECEIVED |
